Publications by authors named "Peter J Olbert"

Claim this Profile
[
[Benign prostatic hyperplasia with bladder emptying disorder in geriatric patients: active (pharmacological or surgical) treatment vs. catheterization].
Peter Jochen Olbert

Aktuelle Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The 1-cm lower calyx calculus: SWT, URS or Mini-PCNL? Guidelines vs. reality.].
Peter Jochen Olbert

Aktuelle Urol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[CpG-ODN instillation boosts ICAM-1 expression in an orthotopic murine UCC model: immunohistochemical evaluation of the local response to immunostimulatory DNA].
Marwin Klebe, Peter Jochen Olbert, Rainer Hofmann, Peter Josef Barth, Axel Hegele

Aktuelle Urol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing blood platelets as RNA biomarker source for prostate cancer.
Jörg Hänze, Peter Jakubowski, Hendrik Heers, Axel Hegele, Nina Timmesfeld, Peter J Olbert

Biomarkers· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphoceles Post-Radical Retropubic Prostatectomy: A Retrospective Evaluation of Epidemiology, Risk Factors and Outcome.
Hendrik Heers, Tobias Laumeier, Peter J Olbert, Rainer Hofmann, Axel Hegele

Urol Int· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells.
Peter J Olbert, Claudia Kesch, Marcus Henrici, Florentine S Subtil, Astrid Honacker

Urol Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TOT approach in stress urinary incontinence (SUI) - outcome in obese female.
Carsten Frohme, Friederike Ludt, Zoltan Varga, Peter J Olbert, Rainer Hofmann

BMC Urol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epithelial mesenchymal transition status is associated with anti-cancer responses towards receptor tyrosine-kinase inhibition by dovitinib in human bladder cancer cells.
Jörg Hänze, Marcus Henrici, Axel Hegele, Rainer Hofmann, Peter J Olbert

BMC Cancer· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolated upper pole access in percutaneous nephrolithotomy: a large-scale analysis from the CROES percutaneous nephrolithotomy global study.
Ahmet Tefekli, Tarik Esen, Peter J Olbert, David Tolley, Robert B Nadler

J Urol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial comment from Dr Olbert to Intravesical Toll-like receptor 7 agonist R-837: optimization of its formulation in an orthotopic mouse model of bladder cancer.
Peter J Olbert

Int J Urol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of the Accordion stone-trapping device: in vitro results from an artificial ureterolithotripsy model.
Peter Jochen Olbert, Christian Keil, Jost Weber, Andres J Schrader, Axel Hegele

Urol Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overweight is associated with improved cancer-specific survival in patients with organ-confined renal cell carcinoma.
Andres Jan Schrader, Julia Rustemeier, Jan Christoph Rustemeier, Nina Timmesfeld, Zoltan Varga, Peter Jochen Olbert

J Cancer Res Clin Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of a 20-min pad test with the 1-hour pad test of the international continence society to evaluate post-prostatectomy incontinence.
Sandra Machold, Peter Jochen Olbert, Axel Hegele, Georg Kleinhans, Rainer Hofmann

Urol Int· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary collecting system invasion in renal cell carcinoma: incidence and long-term prognosis.
Andres Jan Schrader, Julia Rustemeier, Zoltan Varga, Axel Hegele, Peter Jochen Olbert

Int J Urol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
Peter Jochen Olbert, Andres Jan Schrader, Corinna Simon, Alexander Dalpke, Peter Barth

Anticancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic non-clear cell renal cell carcinoma: current therapeutic options.
Andres J Schrader, Peter J Olbert, Axel Hegele, Zoltan Varga, Rainer Hofmann

BJU Int· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre- and perioperative predictors of short-term clinical outcomes in patients undergoing percutaneous nephrolitholapaxy.
Peter J Olbert, Axel Hegele, Andres J Schrader, André Scherag, Rainer Hofmann

Urol Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of a prostate-specific antigen flare phenomenon in patients with hormone-refractory prostate cancer receiving docetaxel.
Peter Jochen Olbert, Axel Hegele, Petra Kraeuter, Axel Heidenreich, Rainer Hofmann

Anticancer Drugs· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis